Description

SHORT DESCRIPTION:

Aptadel Therapeutics is a European preclinical-stage biotech company based in Barcelona, Spain. It focuses on the development of cancer treatments based on Aptamer technologies. Ewing Sarcoma, a rare variety of bone cancer, affecting children, is its lead indication.

 

LONG DESCRIPTION:

Based in
Nation
Founded in

2020

Founding Status

$ 1 Million - $ 2.5 Millions

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected